Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-21

Clinical Trial Update: Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing oral aspirin plus ketamine as an adjunct to standard antidepressant therapy for treatment-resistant depression and major depres…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)
  • Ketamine (ketamine)

Snippet

Sponsor: Theresa Jacob, PhD, MPH | Conditions: Treatment Resistant Depression, Major Depressive Disorder | Phase 4 | Status: COMPLETED